Meredith Ching Disposes 700 ALEX Shares Under 10b5-1 at $16.76
Rhea-AI Filing Summary
Insider sale under 10b5-1 plan. An executive officer, Meredith J. Ching, reported the sale of 700 shares of Alexander & Baldwin, Inc. (ALEX) on 10/10/2025 at a weighted average price of $16.7551 per share. After the sale Ms. Ching beneficially owned 146,849 shares directly, plus 213 shares held by a spouse and 781.571 shares held indirectly through the TCESOP. The filing states the sales were executed pursuant to a Rule 10b5-1 trading plan and that shares were sold in multiple transactions at prices ranging from $16.65 to $17.00. The report is a routine Section 16 disclosure showing a planned, pre-arranged disposition rather than an ad hoc trade.
Positive
- Sale executed under a Rule 10b5-1 trading plan, indicating a pre-arranged disposition
- Complete Section 16 disclosure including weighted average price and price range
Negative
- Reporting person reduced direct holdings by 700 shares on 10/10/2025
Insights
Planned disposition disclosed; compliance with Rule 10b5-1 reduces timing concerns.
The sale of 700 shares was reported as executed under a Rule 10b5-1 plan, which indicates the transactions were pre‑arranged and intended to provide an affirmative defense against insider trading allegations. The filing discloses the weighted average sale price of $16.7551 and the intra-range prices from $16.65 to $17.00.
Because the trade is linked to a scheduled plan, the primary dependency for governance review is whether the plan complies with company policy and applicable timing windows; the disclosure here satisfies Section 16 reporting requirements. Investors and compliance teams can note the remaining direct and indirect holdings—146,849 direct shares plus indirect interests—which contextualize the magnitude of the sale relative to total holdings over the near term.
FAQ
What did Meredith J. Ching report in the Form 4 for ALEX?
Were the shares sold under a pre-arranged plan or as an ad hoc trade?
How many ALEX shares does Meredith J. Ching beneficially own after the sale?
What price range were the shares sold at?
Does this Form 4 indicate any derivative transactions or option exercises?